Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03967938
Title Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes (1-2018 BSMO)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AZ-VUB
Indications

Advanced Solid Tumor

Therapies

Olaparib

Age Groups: senior | adult
Covered Countries BEL


No variant requirements are available.